BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Intestine
,
Autoimmunity
,
Fluoxetine
,
rs2230926
,
TGFB1
,
Coagulation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mitogen activated protein kinase 9
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Liver gene expression profiles of rats treated with dexamethasone and an AMPK activator
Acute monocytic leukemia (AML) THP-1 cells HIV gp120 or LPS stimulated following SB203580 treatment
Synoviocytes of rheumatoid arthritis patients treated with IL17A or IL17F
NIH-3T3 mouse embryonic fibroblasts expressing RasV12 treated with interferon-alpha or U0126
Embryonic kidney cells with MAP4K4 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
Hepatic apoptosis postburn is mediated by c-Jun N-terminal kinase 2.
Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal caus…
c-Jun N-terminal kinase is upregulated in patients with hypospadias.
Activation of c-Jun N-terminal kinase 1/2 regulated by nitric oxide is associated with neuronal surv…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Topical Mitogenic-Activated Protein Kinase (MAPK) Inhibition in Rosacea
p38 Mitogen−Activated Protein Kinase (MAPK) and Steroid Insensitivity in Asthma
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Pro…
Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ